{"schema_version":"1","generated_at":"2026-11-02T02:53:39.838Z","data_as_of":null,"url":"https://www.findmykol.com/kol/seema-naik","json_url":"https://www.findmykol.com/kol/seema-naik/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"seema-naik","name":"Seema Naik","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Pennsylvania State University","institution_url":"https://www.findmykol.com/institution/pennsylvania-state-university","city":"Hershey","state":"PA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1245460575","orcid":"0000-0002-9859-151X","openalex":"A5079889215"},"summary":"Seema Naik is an Oncology physician affiliated with Pennsylvania State University. OpenAlex indexes 154 publications with 1,334 citations (h-index 19); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":154,"cited_by_count":1334,"h_index":19,"latest_activity_year":2025,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT04006847","title":"Omega -3 Fatty Acid in Combination With Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia","phase":"PHASE1/PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"Milton S. Hershey Medical Center","source_url":"https://clinicaltrials.gov/study/NCT04006847","trial_url":"https://www.findmykol.com/trial/NCT04006847"},{"nct":"NCT04002115","title":"Clofarabine Pre-conditioning Followed by Stem Cell Transplant for Non-remission AML","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"Milton S. Hershey Medical Center","source_url":"https://clinicaltrials.gov/study/NCT04002115","trial_url":"https://www.findmykol.com/trial/NCT04002115"}],"source":"trials"},"payments":{"company_count":11,"program_years":{"first":2021,"last":null},"rows_total":17,"shown":3,"withheld":14,"rows":[{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":143.24,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1245460575"},{"payer":"Janssen Biotech, Inc.","program_year":2025,"amount_usd":123.07,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1245460575"},{"payer":"Novartis Pharmaceuticals Corporation","program_year":2025,"amount_usd":115.59,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1245460575"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1245460575","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"MCL-1493: Fixed-Duration Outpatient Subcutaneous Mosunetuzumab + Polatuzumab Vedotin Shows Robust Efficacy in a Phase 2 Study of Relapsed/Refractory (R/R) Post-BTK Inhibitor Mantle Cell Lymphoma (MCL)","year":2025,"journal":"Clinical Lymphoma Myeloma & Leukemia","source_url":"https://doi.org/10.1016/s2152-2650(25)02485-1","status":"verified"},{"title":"IMPROVE-BMT: A Pilot Randomized Controlled Trial of Prehabilitation Exercise for Adult Hematopoietic Stem Cell Transplant Recipients","year":2024,"journal":"Journal of Clinical Medicine","source_url":"https://doi.org/10.3390/jcm13072052","status":"verified"},{"title":"A Randomized Phase II Study of Mosunetuzumab SC Plus Polatuzumab Vedotin Demonstrates Improved Outcomes Versus Rituximab Plus Polatuzumab Vedotin in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)","year":2024,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2024-194581","status":"verified"},{"title":"Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation","year":2024,"journal":"Leukemia Research","source_url":"https://doi.org/10.1016/j.leukres.2024.107530","status":"verified"},{"title":"Mosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell lymphoma: a phase 1b/2 trial","year":2023,"journal":"Nature Medicine","source_url":"https://doi.org/10.1038/s41591-023-02726-5","status":"verified"}],"source":"works"},"contact":{"address_1":"500 UNIVERSITY DR","city":"Hershey","state":"PA","zip":"170332360","phone":"717-531-8401","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1245460575","source":"identity"},"similar":[{"name":"Richard Legro","slug":"richard-legro","institution":"Pennsylvania State University","specialty":"Reproductive Endocrinology","url":"https://www.findmykol.com/kol/richard-legro","json_url":"https://www.findmykol.com/kol/richard-legro/profile.json"},{"name":"Ramin Zand","slug":"ramin-zand","institution":"Pennsylvania State University","specialty":"Neurological Surgery","url":"https://www.findmykol.com/kol/ramin-zand","json_url":"https://www.findmykol.com/kol/ramin-zand/profile.json"},{"name":"Allan Lipton","slug":"allan-lipton","institution":"Pennsylvania State University","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/allan-lipton","json_url":"https://www.findmykol.com/kol/allan-lipton/profile.json"},{"name":"Steven Ettinger","slug":"steven-ettinger","institution":"Pennsylvania State University","specialty":"Interventional Cardiology","url":"https://www.findmykol.com/kol/steven-ettinger","json_url":"https://www.findmykol.com/kol/steven-ettinger/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":14,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2017-05-08","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}